ovarian cancer therapies (ATI)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Nameovarian cancer therapies (ATI)

Drug Alias Nameovarian cancer therapies (Anticancer Therapeutic Inventions)ATI-OC-1ATI-OC-2

ClassificationSmall moleculesRadiation-emitting products > Radioactive therapeutic agent

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNorway

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAlgeta ASA

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAlgeta ASA

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

ATC CodeN/A